160 related articles for article (PubMed ID: 9663638)
1. Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users.
Rich JD; Dickinson BP; Liu KL; Case P; Jesdale B; Ingegneri RM; Nolan PA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S140-1. PubMed ID: 9663638
[No Abstract] [Full Text] [Related]
2. Lower syringe sharing and re-use after syringe legalization in Rhode Island.
Rich JD; Hogan JW; Wolf F; DeLong A; Zaller ND; Mehrotra M; Reinert S
Drug Alcohol Depend; 2007 Jul; 89(2-3):292-7. PubMed ID: 17386980
[TBL] [Abstract][Full Text] [Related]
3. Syringe access for injection drug users in Rhode Island.
Boutwell A; Rich JD
Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
[No Abstract] [Full Text] [Related]
4. Maine removed criminal penalties for syringe possession in 1997 after allowing sale of syringes without a prescription in 1993.
Beckett GA; Galena R; Shields D; Mills DA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S145-6. PubMed ID: 9663642
[No Abstract] [Full Text] [Related]
5. In New York City, syringe laws and regulations deter physicians and pharmacists from prescribing and selling syringes to persons who may be injection drug users.
Lazzarini Z; Schoenbaum EE; O'Neill CH
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S141-3. PubMed ID: 9663639
[No Abstract] [Full Text] [Related]
6. Following the blood: syringe reuse leads to blood-borne virus transmission among injection drug users.
Koester S
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S139-40. PubMed ID: 9663637
[No Abstract] [Full Text] [Related]
7. Oregon's exclusion of syringes from its 1987 drug paraphernalia law was an HIV prevention measure.
Wright LN; Gebbie KM
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S144-5. PubMed ID: 9663641
[No Abstract] [Full Text] [Related]
8. Obstacles to needle exchange participation in Rhode Island.
Rich JD; Strong L; Towe CW; McKenzie M
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):396-400. PubMed ID: 10458620
[TBL] [Abstract][Full Text] [Related]
9. A syringe prescription program to prevent infectious disease and improve health of injection drug users.
Rich JD; McKenzie M; Macalino GE; Taylor LE; Sanford-Colby S; Wolf F; McNamara S; Mehrotra M; Stein MD
J Urban Health; 2004 Mar; 81(1):122-34. PubMed ID: 15047791
[TBL] [Abstract][Full Text] [Related]
10. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
Wright-De Agüero L; Weinstein B; Jones TS; Miles J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
[TBL] [Abstract][Full Text] [Related]
11. [Intravenous drug use and the spread of HIV; an international perspective].
Meijerink H; van Crevel R; van der Ven AJ
Ned Tijdschr Geneeskd; 2013; 157(21):A5690. PubMed ID: 23693006
[TBL] [Abstract][Full Text] [Related]
12. High street prices of syringes correlate with strict syringe possession laws.
Rich JD; Foisie CK; Towe CW; McKenzie M; Salas CM
Am J Drug Alcohol Abuse; 2000 Aug; 26(3):481-7. PubMed ID: 10976670
[TBL] [Abstract][Full Text] [Related]
13. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies.
Kral AH; Anderson R; Flynn NM; Bluthenthal RN
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1307-12. PubMed ID: 15385739
[TBL] [Abstract][Full Text] [Related]
14. Syringe prescription to prevent HIV infection in Rhode Island: a case study.
Rich JD; Macalino GE; McKenzie M; Taylor LE; Burris S
Am J Public Health; 2001 May; 91(5):699-700. PubMed ID: 11344871
[TBL] [Abstract][Full Text] [Related]
15. Prescribing syringes to injection drug users with HIV: an important clinical and public health tool.
Stozek MA; Taylor LE; LeBreux L; Olson J; Wolf F; Rich JD
J Assoc Nurses AIDS Care; 2004; 15(2):59-63. PubMed ID: 15090134
[No Abstract] [Full Text] [Related]
16. HIV/AIDS in China. Changing course to break the HIV-heroin connection.
Cohen J
Science; 2004 Jun; 304(5676):1434-5. PubMed ID: 15178779
[No Abstract] [Full Text] [Related]
17. Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT.
Singer M; Himmelgreen D; Weeks MR; Radda KE; Martinez R
Med Anthropol; 1997 Dec; 18(1):107-30. PubMed ID: 9458670
[TBL] [Abstract][Full Text] [Related]
18. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
19. The sharing of injecting paraphernalia among illicit drug users.
Power R; Hunter GM; Jones SG; Donoghoe MC
AIDS; 1994 Oct; 8(10):1509-11. PubMed ID: 7818831
[No Abstract] [Full Text] [Related]
20. Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island.
Mitty JA; Bazerman LB; Selwyn K; Beckwith CG; Zaller ND; Rich JD
AIDS Read; 2008 Dec; 18(12):596-600. PubMed ID: 19123275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
